126 related articles for article (PubMed ID: 26088584)
1. [Urinary stones and bowel diseases: Systematic review].
Pradere B; Peyronnet B; Brochard C; Le Balc'h É; Vigneau C; Siproudhis L; Traxer O; Bensalah K
Prog Urol; 2015 Sep; 25(10):557-64. PubMed ID: 26088584
[TBL] [Abstract][Full Text] [Related]
2. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
Vaidyanathan S; von Unruh GE; Watson ID; Laube N; Willets S; Soni BL
ScientificWorldJournal; 2006 Apr; 6():2403-10. PubMed ID: 17619709
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
Troxel SA; Sidhu H; Kaul P; Low RK
J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
[TBL] [Abstract][Full Text] [Related]
4. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
[TBL] [Abstract][Full Text] [Related]
5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
6. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
Siener R; Bangen U; Sidhu H; Hönow R; von Unruh G; Hesse A
Kidney Int; 2013 Jun; 83(6):1144-9. PubMed ID: 23536130
[TBL] [Abstract][Full Text] [Related]
7. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
[TBL] [Abstract][Full Text] [Related]
8. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation.
Kumar R; Ghoshal UC; Singh G; Mittal RD
J Gastroenterol Hepatol; 2004 Dec; 19(12):1403-9. PubMed ID: 15610315
[TBL] [Abstract][Full Text] [Related]
9. [Nephrolithiasis in patients with intestinal diseases].
Cirillo M; Iudici M; Marcarelli F; Laudato M; Zincone F
G Ital Nefrol; 2008; 25(1):42-8. PubMed ID: 18264917
[TBL] [Abstract][Full Text] [Related]
10. Renal lithiasis and inflammatory bowel diseases, an update on pediatric population.
Bianchi L; Gaiani F; Bizzarri B; Minelli R; Cortegoso Valdivia P; Leandro G; Di Mario F; De' Angelis GL; Ruberto C
Acta Biomed; 2018 Dec; 89(9-S):76-80. PubMed ID: 30561398
[TBL] [Abstract][Full Text] [Related]
11. Oxalobacter formigenes: Opening the door to probiotic therapy for the treatment of hyperoxaluria.
Jairath A; Parekh N; Otano N; Mishra S; Ganpule A; Sabnis R; Desai M
Scand J Urol; 2015; 49(4):334-7. PubMed ID: 25645091
[TBL] [Abstract][Full Text] [Related]
12. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
[TBL] [Abstract][Full Text] [Related]
13. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria.
Hoppe B; Leumann E; von Unruh G; Laube N; Hesse A
Front Biosci; 2003 Sep; 8():e437-43. PubMed ID: 12957811
[TBL] [Abstract][Full Text] [Related]
15. Impact of intestinal flora on calcium oxalate stones.
Wang C; Dong X; Yin X; Zhou F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Nov; 46(11):1285-1289. PubMed ID: 34911864
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori and urinary system stones: endoluminal damage as sub-hypothesis to support the current stone theory.
Verit A; Güner ND
Med Hypotheses; 2014 Dec; 83(6):677-80. PubMed ID: 25459132
[TBL] [Abstract][Full Text] [Related]
17. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
18. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
[TBL] [Abstract][Full Text] [Related]
19. Urolithiasis in children: current medical management.
Laufer J; Boichis H
Pediatr Nephrol; 1989 Jul; 3(3):317-31. PubMed ID: 2702115
[TBL] [Abstract][Full Text] [Related]
20. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
